LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Urothelial Carcinoma
Related studies linked through entity extraction aliases.
Study to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy
- Status
- RECRUITING
- Phase
- NA
Safety & Efficacy of Durvalumab+Neoadjuvant Chemotherapy for High-risk Urothelial Carcinoma of the Upper Urinary Tract
- Status
- RECRUITING
- Phase
- PHASE2
GEN-001 (Live Biotherapeutic Product) and Avelumab Combination Study for Patients With Solid Tumors Who Have Progressed on Anti-PD-(L)1 Therapy
- Status
- COMPLETED
- Phase
- PHASE1
TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy
- Status
- TERMINATED
- Phase
- PHASE1
An Umbrella Study to Determine the Safety and Efficacy of Various Monotherapy or Combination Therapies in Neoadjuvant Urothelial Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Neoadjuvant Durvalumab Alone Versus Durvalumab With Olaparib in Patients Ineligible for Cisplatin With Muscle-Invasive Urothelial Carcinoma of the Bladder Followed by Radical Cystectomy
- Status
- TERMINATED
- Phase
- PHASE2
Evolution of Proteomic Profiles of Intestinal Microbiota in Patients With Locally Advanced or Metastatic Urothelial Carcinomas
- Status
- COMPLETED
- Phase
- N/A
A Study of ICP-192 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Neoadjuvant Toripalimab in Combination With Gemcitabine Therapy in Cisplatin Ineligible Local Advanved Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Fear of Cancer Recurrence in Genitourinary Cancer
- Status
- COMPLETED
- Phase
- N/A
A Multicenter Cancer Biospecimen Collection Study
- Status
- RECRUITING
- Phase
- N/A
Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of the Safety and Tolerance of CAN04 and Pembrolizumab in Combination With and Without Carboplatin and Pemetrexed in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Prospective, Multi-centre, Single-blinded Study of UroCAD for Urothelial Carcinoma Diagnosis and Follow-up
- Status
- UNKNOWN
- Phase
- N/A
Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Investigating Marrow Infiltrating Lymphocytes in Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- NA
Intermittent Checkpoint Inhibitor Therapy In Patients With Advanced Urothelial Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2